Product
ACA-001 (Pancreatic Cancer)
PHARMACEUTICAL
byACA Therapeutics
United States (US)
ABOUT THE PRODUCT
ACA-001 is a Phase I Clinical Study that is officially Active and Approved, targeting pancreatic cancer.
Information is owner-confirmed
Last updated 4 months ago
Price range